| Literature DB >> 31878127 |
Concettina Cappadone1, Manuela Mandrone2, Ilaria Chiocchio2, Cinzia Sanna3, Emil Malucelli1, Vincenza Bassi1, Giovanna Picone1, Ferruccio Poli2.
Abstract
Sardinia (Italy), with its wide range of habitats and high degree of endemism, is an important area for plant-based drug discovery studies. In this work, the antitumor activity of 35 samples from Sardinian plants was evaluated on human osteosarcoma cells U2OS. The results showed that five plants were strongly antiproliferative: Arbutus unedo (AuL), Cynara cardunculus (CyaA), Centaurea calcitrapa (CcA), Smilax aspera (SaA), and Tanacetum audibertii (TaA), the latter endemic to Sardinia and Corsica. Thus, their ability to induce cell cycle arrest and apoptosis was tested. All extracts determined cell cycle block in G2/M phase. Nevertheless, the p53 expression levels were increased only by TaA. The effector caspases were activated mainly by CycA, TaA, and CcA, while AuL and SaA did not induce apoptosis. The antiproliferative effects were also tested on human umbilical vein endothelial cells (HUVEC). Except for AuL, all the extracts were able to reduce significantly cell population, suggesting a potential antiangiogenic activity. The phytochemical composition was first explored by 1H NMR profiling, followed by further purifications to confirm the structure of the most abundant metabolites, such as phenolic compounds and sesquiterpene lactones, which might play a role in the measured bioactivity.Entities:
Keywords: NMR profiling; Sardinian plants; antitumor activity; apoptosis; cell cycle; sesquiterpene lactones
Year: 2019 PMID: 31878127 PMCID: PMC7020228 DOI: 10.3390/plants9010026
Source DB: PubMed Journal: Plants (Basel) ISSN: 2223-7747
Ethnobotanical use of investigated plants in Sardinian traditional medicine. Up-to-date information on plants analyzed in this work. Traditional uses related to specific organs as well as preparation are reported.
| Plant Species | Plant Organ and Label | Ethnobotanical Use in Sardinia | Preparation |
|---|---|---|---|
|
| Fruits (AuF) | Astringent [ | Decoction |
| wound healing [ | Cataplasm | ||
| Leaves (AuL) | Inflammations of intestine, kidney, bladder [ | Decoction (together with fruits and roots) | |
| Antipyretic, diarrhea [ | Decoction | ||
|
| Rhizome (ArRh) | Sore throat, skin diseases [ | Decoction |
| Skin disease (chilblain) [ | Cataplasm | ||
| Leaves (ArL) | Diuretic (not recommended for patients affected by rheumatisms) [ | Decoction | |
|
| Leaves (CgL) | Diuretic [ | Decoction and infusion |
|
| Aerial parts (CcA) | Antipyretic, digestive, for constipation and diarrhea [ | Decoction |
| Antiseptic [ | Juice | ||
|
| Aerial parts (ChA) | N.D. * | - |
|
| Aerial parts (CnA) | Nutritional purposes: aerial parts are often included in the diet [ | Direct ingestion |
|
| Aerial parts (CmA) | Topically for wound healing [ | Poultice obtained by pressing fresh leaves between two pieces of wood |
|
| Aerial parts | N.D. * | - |
|
| Aerial parts (CycA) | Hepatoprotective, blood depurative, hypocholesterolemic, digestive, intestinal spasmolytic [ | Decoction |
| Liver diseases [ | Infusion | ||
|
| Leaves (FaL) | N.D. * | - |
| Roots | N.D. * | - | |
|
| Aerial parts (GtA) | Nutritional purposes: aerial parts are often included in the diet [ | Direct ingestion |
|
| Aerial parts, flowers (GcA) | In Corse, flowers were used as disinfectant of wounds and abrasions [ | Infusion |
|
| Aerial parts (GsA) | Treatment of respiratory diseases, chronic catarrh, bronchitis, asthma, and to heal wounds [ | Infusion of steam and flowers in water or milk |
|
| Aerial parts (HhA) | Burns and wounds healing [ | Macerated in olive oil |
| For rheumatic and sciatic pains and for dislocations and sprains [ | Macerated in olive oil and white wine, followed by evaporation of the wine | ||
|
| Aerial parts | N.D. * | - |
|
| Aerial parts (LsA) | Against ringworm and skin diseases, and for wounds healing [ | Macerated in spirit |
| Treatment of migraine, vertigo, asthma, palpitation, whooping cough, laryngitis, bronchitis, rheumatism [ | Infusion | ||
| Treatment of skin diseases [ | Direct application of leaves | ||
|
| Aerial parts (LmA) | N.D. * | - |
|
| Fruits (McF) | Vulnerary, cough, sedative, digestive [ | Decoction |
| Against cough and catarrh [ | Decoction (together with leaves) | ||
| Digestive [ | Macerated in spirit | ||
| Leaves (McL) | Wound healing [ | Dried and powdered for topical application | |
| Digestive and as an agent to treat respiratory ailments, as vulnerary, against hemorrhoids, to treat sweaty feet [ | Infusion | ||
| Digestive, treatment of respiratory inflammations and hemorrhoids [ | Fresh leaves pack | ||
| Vulnerary, cough, sedative, digestive [ | Decoction | ||
|
| Fruits (PlF) | Cutaneous inflammations [ | Fresh-squeezed and heated for topical application |
| Halitosis [ | Fresh fruits | ||
| Catarrhal cough, gingivitis, sore throat [ | Decoction | ||
| Leaves (PlL) | Treatment of gingivitis, sore throat [ | Decoction of fresh leaves to use as mouthwash | |
| Stomatitis, cough sedative, skin diseases [ | Decoction | ||
| Against ticks [ | Fumigation | ||
| Anticatarrhal [ | Infusion | ||
|
| Leaves (PtL) | Catarrhal cough [ | Decoction |
|
| Aerial parts (PfA) | N.D. * | - |
|
| Aerial parts (PcA) | Antispasmodic [ | Direct ingestion |
|
| Aerial parts (RoA) | Stomachache [ | Infusion |
| Hepatic [ | Decoction | ||
| Antirheumatic [ | Cataplasm | ||
|
| Aerial parts | N.D. * | |
|
| Aerial parts (ShA) | Nutritional purposes: young stems are often included in the diet [ | Direct ingestion |
|
| Aerial parts | Treatment of bleeding, diuretic, hypotensive, sudorifer in case of pneumonia and chronic catarrh [ | Decoction (together with the seeds) |
|
| Aerial parts (SaA) | Treatment of rheumatisms, skin diseases [ | Cataplasm |
| Sudorific and blood cleanser [ | Decoction | ||
| Toothache [ | Drops of fresh-squeezed juice applied on the gums | ||
|
| Aerial parts (SgA) | Antiseptic, antispasmodic [ | Infusion |
| Cholagogue, diuretic, and hepatoprotective [ | Decoction | ||
|
| Aerial parts (TaA) | Digestive, vermifuge, antiarthritic and to treat menstrual disorders [ | Decoction |
|
| Aerial parts | Antitussive, expectorant, antispasmodic, collutory [ | Decoction or infusion |
| Against foot perspiration and urticaria [ | Powder obtained by crushing aerial parts | ||
| Rheumatisms [ | Cataplasm | ||
| Catarrhal, antipyretic [ | Macerated in wine | ||
| Lung diseases [ | Vaporization |
a Endemic species of Sardinia; b endemic to Sardinia and Corsica; c endemic to Sardinia, Corsica, and Tuscan Archipelago; d endemic to Sardinia (Italy), Corsica, and the Hyères islands (France); e endemic to Sardinia, Corsica, and Majorca (Spain); * N.D. = Not documented, there are no published data on the ethnobotanical use of these plants.
Figure 1Antiproliferative effects of plant extracts on U2OS cells. (A) Screening of all extracts on viability of U2OS cells treated at 50 and 100 μg/mL concentrations. Bars indicate the means of six replicated experiments and represent the percentage of viable cells with respect to the control taken arbitrarily as 100%. (B) Dose–response curves of U2OS cell viability after treatment with the five most active extracts for 48 h.
Figure 2Effects of most potent plant extracts on cell cycle progression and p53 levels. (A) Cell cycle distribution of U2OS after 48 h of treatment with the plant extracts. Data are presented as means ± SD of three different experiments. Differences were considered significant when p ≤ 0.05 (* p ≤ 0.05; ** p ≤ 0.05; *** p ≤ 0.001). (B) Flow cytometric analysis of p53 protein levels after CycA or TaA treatment. The histograms represent the protein expression levels with respect to the control taken arbitrarily as 100%. Results shown are representative data from three similar experiments.
Figure 3Apoptotic effects on U2OS cells treated for 48 h with the selected extracts: morphological changes and caspase activity. (A) Images acquired by optical microscope. (B) Images acquired by fluorescence microscope after HOECHST staining. (All the images were taken at the same magnification and depict microscopic fields representative of the whole cell population.) (C) Caspase activity assay (fold change of protein activity was calculated by taking untreated cells as a control = 1). Bar graphs represent means ± SD determined from at least three independent experiments. Differences were considered significant when p ≤ 0.05 (* p ≤ 0.05; *** p ≤ 0.001).
Effects of five most active plant extracts on U2OS and HUVEC cell viability. Cells were treated at 50 and 100 μg/mL concentrations for 24 h. Data are presented as means ± SD of three replicated experiments and represent the percentage of viable cells with respect to the control taken arbitrarily as 100%.
| Extracts | U2OS Cells | HUVEC Cells | ||
|---|---|---|---|---|
| 50 μg/mL | 100 μg/mL | 50 μg/mL | 100 μg/mL | |
|
| 79.6 ± 7.7 | 56 ± 5.5 | 111.8 ± 0.63 | 104.7 ± 4.6 |
|
| 90 ± 2 | 50 ± 6.5 | 6.5 ± 0.29 | 6.4 ± 0.05 |
|
| 45 ± 1.4 | 29 ± 9.9 | 6.5 ± 0.02 | 7.7 ± 0.37 |
|
| 85.4 ± 5.5 | 68.3 ± 0.7 | 114.2 ± 0.08 | 77.3 ± 1.11 |
|
| 96.9 ± 12.9 | 56.9 ± 3.9 | 98.9 ± 0.07 | 50.4 ± 1.5 |
Figure 41H NMR extended spectral regions of AuL; CcA; SaA; TaA; CycA (from top to bottom). (A) region from δ 0.4 to 3.4; (B) from δ 3.4 to 5.4; (C) from δ 5.4 to 8.1; (D) from δ 7.8 to 10.00. Numbers indicate diagnostic signals of the most abundant metabolites: O-rhamnosyl flavonoid (1), valine (2), alanine (3), cynaropicrin (4), quinic acid (5), shikimic acid (6), succinic acid (7), malic acid (8), aspartic acid (9), sucrose (10), β-glucose (11), arbutin (12), α-glucose (13), sesquiterpene lactone-derivative (14), caffeic acid (15), trigonelline (16), formic acid (17). Spectra were measured in D2O-buffer (pH 6.0) using TMSP as standard, residual water signal has been removed.
Estimated amount of metabolites by 1H NMR analysis.
| Metabolite | Diagnostic 1H NMR Signal (δ) Used for the Quantification and Number of Underlying Proton/s (in Brackets) | Metabolite Quantity in the Extract (μg/mg of Extract) | ||||
|---|---|---|---|---|---|---|
| AuL | CycA | CcA | TaA | SaA | ||
|
| 1.48 (3H) | 1.4 | 2.0 | - | 8.9 | 3.7 |
|
| 7.07 (2H) | 75 | - | - | - | - |
|
| 2.96 (1H) | - | - | 17 | 33 | - |
|
| 7.62 (1H) | - | - | - | - | 13 |
|
| 6.16 (1H) | - | 159 | - | - | - |
|
| 5.2 (1H) | 22 | 24 | - | - | 40 |
|
| 4.59 (1H) | 36 | 49 | - | 34 | 88 |
|
| 1.06 (3H) | - | - | - | - | 19 |
|
| 1.87 (1H) | 142 | 43 | - | - | 193 |
|
| 6.45 (1H) | - | - | - | - | 141 |
|
| 5.4 (1H) | 138 | - | - | 45 | 79 |
NMR spectral references for cynaropicrin. Spectra of the purified fraction were measured in CD3OD. Splitting patterns and coupling constants were determined by J-res experiment.
| Position | 1H (δ; J) | 13C (δ) | HMBC | COSY |
|---|---|---|---|---|
|
| 3.00 (ddd; J = 11.53; 10.65 Hz; 6.84) | 46.22 | 39.78; 51.32; 74.18; 118.11; 142.84 | 2.09; 1.74; 2.88 |
|
| 2.09 (ddd; J = 13.14; 7.50; 6.84 Hz) | 39.78 | 46.22; 51.32; 74.18; 142.84 | 1.74; 3.00; 4.49 |
|
| 1.74 (ddd; J = 13.14; 11.53; 8.80 Hz) | 39.78 | 46.22; 74.18; 152.92 | 2.09; 3.00; 4.49 |
|
| 4.49 (dd; J = 8.80; 7.60 Hz) | 74.18 | 152.92 | 2.09; 1.74; 5.43; 5.64 |
|
| - | 152.92 | - | - |
|
| 2.88 (ddd; J = 10.65; 9.21 Hz) | 51.32 | 79.81 | 3.00; 4.33; 4.91; 5.33 |
|
| 4.33 (dd; J = 11.06; 8.89 Hz) | 79.81 | 75.15 | 2.88; 3.27 |
|
| 3.27 (m) | 41.48 | ov. | 4.33; 5.15; 6.12; 5.64 |
|
| 5.15 (m) | 75.15 | ov. | 3.27 |
|
| 2.73 (dd; J = 14.65; 5.26 Hz) | 37.14 | 118.11; 142.84 | 2.40; 4.91; 5.15 |
|
| 2.40 (dd; J = 14.65; 3.50 Hz) | 37.14 | 118.11; 142.84 | 2.73; 4.91; 5.15 |
|
| - | 142.84 | - | - |
|
| - | 138.77 | - | - |
|
| - | 170.01 | - | - |
|
| 6.12 (d; J = 3.30 Hz) | 121.96 | 41.48; 138.77; 170.01 | 3.27; 5.64 |
|
| 5.64 (d; J = 3.30 Hz) | 121.96 | 41.48; 138.77; 170.01 | 3.27; 6.12 |
|
| 5.14 (d; J = 2.09 Hz) | 118.11 | 37.14; 46.22; 142.84 | 2.40; 2.73; 4.91 |
|
| 4.91 (d; J = 2.09 Hz) | 118.11 | 37.14; 46.22; 142.84 | 2.40; 2.73; 5.14 |
|
| 5.43 (d; J = 1.97 Hz) | 122.36 | 51.32; 74.18; 152.92 | 2.88; 4.49; 5.33 |
|
| 5.33 (d; J = 1.97 Hz) | 122.36 | 51.32; 74.18; 152.92 | 2.88; 4.49; 5.43 |
|
| - | 165.28 | - | - |
|
| - | 140.80 | - | - |
|
| 6.30 (d; J = 1.40 Hz) | 125.70 | 61.73; 140.80; 165.28 | 4.30; 5.97 |
|
| 5.97 (d; J = 1.40 Hz) | 125.70 | 61.73; 140.80; 165.28 | 4.30; 6.30 |
|
| 4.30 (s) | 61.73 | 125.70;140.80; 165.28 | 5.97; 6.30 |
List of the plants analyzed in this work. Plant name, family, considered plant organ and adopted label, harvesting date and GPS coordinates, and voucher number are reported.
| Plant Name | Family | Plant Organ and Sample Label in Brackets | GPS Coordinates | HARVESTING DATE | Voucher |
|---|---|---|---|---|---|
|
| Ericaceae | Fruits (AuF) | 39°45′37.8″ N | December 2017 | Herbarium CAG 878 |
| Leaves (AuL) | 39°45′37.8″ N | December 2017 | |||
|
| Asphodelaceae | Rhizome (ArRh) | 39°10′38.7″ N | April 2017 | Herbarium CAG 1405 |
| Leaves (ArL) | 39°10′38.7″ N | April 2017 | |||
|
| Asteraceae | Leaves (CgL) | 39°45′44.2″ N | July 2018 | Herbarium CAG 770 |
|
| Asteraceae | Aerial parts (CcA) | 39°18′02.3″ N | June 2017 | Herbarium CAG 781 |
|
| Asteraceae | Aerial parts (ChA) | 40°57′51.6″ N | June 2017 | Herbarium CAG 777 |
|
| Asteraceae | Aerial parts (CnA) | 39°16′51.5″ N | June 2017 | Herbarium CAG 784 |
|
| Cistaceae | Aerial parts (CmA) | 39°45′44.2″ N | April 2018 | Herbarium CAG 135 |
|
| Cistaceae | Aerial parts (CsA) | 39°45′44.2″ N | April 2018 | Herbarium CAG 135/C |
|
| Asteraceae | Aerial parts (CycA) | 39°18′02.3″ N | April 2017 | Herbarium CAG 790 |
|
| Apiaceae | Leaves (FaL) | 39°51′37.9″ N | April 2017 | Herbarium CAG 612/A |
| Roots (FaR) | 39°51′37.9″ N | April 2017 | |||
|
| Asteraceae | Aerial parts (GtA) | 39°46′16.7″ N | September 2018 | Herbarium CAG 789 |
|
| Fabaceae | Aerial parts (GcA) | 39°49′35.0″ N | May 2017 | Herbarium CAG 286 |
|
| Lamiaceae | Aerial parts (GsA) | 39°57′33.5″ N | June 2017 | Herbarium CAG 1104 |
|
| Hypericaceae | Aerial parts (HhA) | 39°46′55.8″ N | June 2018 | Herbarium CAG 232 |
|
| Hypericaceae | Aerial parts (HsA) | 39°45′57.4″ N | June 2018 | Herbarium CAG 239/C |
|
| Lamiaceae | Aerial parts (LsA) | 39°45′44.2″ N | April 2017 | Herbarium CAG 1067 |
|
| Plumbaginaceae | Aerial parts (LmA) | 39°54′33.3″ N | December 2017 | Herbarium CAG 909/G |
|
| Myrtaceae | Fruits (McF) | 39°45′44.2″ N | December 2018 | Herbarium CAG 514 |
| Leaves (McL) | 39°08′22.2″ N | April 2018 | |||
|
| Anacardiaceae | Fruits (PlF) | 39°45′44.2″ N | December 2017 | Herbarium CAG 280 |
| Leaves (PlL) | December 2017 | ||||
|
| Anacardiaceae | Leaves (PtL) | 39°47′38.8″ N | June 2018 | Herbarium CAG 279 |
|
| Asteraceae | Aerial parts (PfA) | 39°21′45.2″ N | July 2017 | Herbarium CAG 743 |
|
| Asteraceae | Aerial parts (PcA) | 39°53′52.7″ N | June 2018 | Herbarium CAG 796 |
|
| Lamiaceae | Aerial parts (RoA) | 40°34′10.1″ N | May 2017 | Herbarium CAG 1091 |
|
| Asteraceae | Aerial parts (ScA) | 40°32′30.6″ N | November 2017 | Herbarium CAG 732/A |
|
| Asteraceae | Aerial parts (ShA) | 39°03′25.9″ N | June 2018 | Herbarium CAG 812 |
|
| Asteraceae | Aerial parts (SmA) | 39°16′51.5″ N | May 2017 | Herbarium CAG 801 |
|
| Smilacaceae | Aerial parts (SaA) | 39°10′38.7″ N | May 2017 | Herbarium CAG 1414 |
|
| Lamiaceae | Aerial parts (SgA) | 39°55′46.1″ N | June 2017 | Herbarium CAG 1099 |
|
| Asteraceae | Aerial parts (TaA) | 40°02′07.9″ N | August 2018 | Herbarium CAG 737/A |
|
| Lamiaceae | Aerial parts (ThA) | 39°56′01.2″ N | June 2017 | Herbarium CAG 1065 |
* Endemic species of Sardinia; ** Endemic to Sardinia and Corsica; + Endemic to Sardinia, Corsica, and Tuscan Archipelag; ++ Endemic to Sardinia (Italy), Corsica, and the Hyères islands (France); § Endemic to Sardinia, Corsica, and Balearic Islands (Spain).